NEUPHORIA THERAPEUTICS INC. (NEUP)
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
Rithm Property Trust Inc. Declares Second Quarter 2026 Common and Preferred Stock Dividends
Crescent Biopharma Announces Grants of Inducement Awards
Coppernico Metals Closes $5.5 Million LIFE Offering
WM Sets Date for Second Quarter 2026 Earnings Conference Call
Employers Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call
ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND, INC. REPORTS SECOND QUARTER EARNINGS
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease
Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease